COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Thromboelastogram During Total Knee Replacement

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02373969
Recruitment Status : Completed
First Posted : February 27, 2015
Last Update Posted : April 6, 2016
Information provided by (Responsible Party):
Rambam Health Care Campus

Brief Summary:
Verify the changes in coagulation system during total knee replacement surgery with tranexamic acid single bolus infusion.

Condition or disease
Orthopedic Procedures, Tranexamic Acid

Detailed Description:
The study was set to reveal changes in the coagulation and fibrinolytic systems during total knee surgery and especially during tourniquet placement, tourniquet removal and revascularization of ischemic limb, after tranexamic acid single bolus infusion, and at post operative day 1.

Layout table for study information
Study Type : Observational
Actual Enrollment : 30 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Thromboelastogram During Surgery for Total Knee Replacement With Tourniquet Application and Single Dose Tranexamic Acid
Study Start Date : August 2011
Actual Primary Completion Date : January 2012
Actual Study Completion Date : January 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Knee Replacement

Primary Outcome Measures :
  1. Change in coagulation status during and after surgery compared to pre-surgery [ Time Frame: During and after surgery compared to pre-surgery ]
  2. Change in fibrinolytic activity during and after surgery compared to pre-surgery [ Time Frame: During and after surgery compared to pre-surgery ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
As described in eligibility criteria

Inclusion Criteria:

  • Osteoarthrosis
  • TKR operation elective

Exclusion Criteria:

  • TKR due to any reason but osteoarthrosis
  • known coagulation problems
  • platelets < 100,000/DcL
  • Hb < 12 g%
  • past thrombo-embolic event
  • treatment with aspiring during last week
  • treatment with NSAID's during last 48 hours
  • malignancy
  • known allergy to tranexamic acid
  • general anesthesia
Layout table for additonal information
Responsible Party: Rambam Health Care Campus Identifier: NCT02373969    
Other Study ID Numbers: TEG-099-11
First Posted: February 27, 2015    Key Record Dates
Last Update Posted: April 6, 2016
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No